EV/EBITDA
-12.12
-1.29-11.91%
Sat, 04 Jan 2025 00:15:41 GMT
Summary:
10x Genomics EV/EBITDA is currently -12.12, with a fall of -1.29 (-11.91%) during the most recent trading day. Over the past year, it has increased by +16.04 (+56.96%). TXG EV/EBITDA is now -41.92% below its all-time high of -8.54.TXG EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXG EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -11.9% |
| 1 m1 month | +1.0% |
| 3 m3 months | +22.2% |
| 6 m6 months | -15.5% |
| ytdytd | -11.0% |
| 1 y1 year | +57.0% |
| 5 y5 years | +96.3% |
TXG EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -9.95 | -21.8% | -12.89 | +6.0% |
| 3 m | 3 months | -9.95 | -21.8% | -16.58 | +26.9% |
| 6 m | 6 months | -8.54 | -41.9% | -18.53 | +34.6% |
| 1 y | 1 year | -8.54 | -41.9% | -29.73 | +59.2% |
| 3 y | 3 years | -8.54 | -41.9% | -646.40 | +98.1% |
| 5 y | 5 years | -8.54 | -41.9% | -660.90 | +98.2% |
| alltime | all time | -8.54 | -41.9% | -660.90 | +98.2% |
10x Genomics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -12.12(+11.0%) |
| 2024 | -10.92(-64.9%) |
| 2023 | -31.14(-1.8%) |
| Date | Value |
|---|---|
| 2022 | -31.70(-95.2%) |
| 2021 | -660.90(+2200.4%) |
| 2020 | -28.73(-91.4%) |
| 2019 | -332.44 |
FAQ
- What is 10x Genomics EV/EBITDA?
- What is the all time high EV/EBITDA for 10x Genomics?
- What is TXG EV/EBITDA year-to-date change?
- What is 10x Genomics EV/EBITDA year-on-year change?
What is 10x Genomics EV/EBITDA?
The current EV/EBITDA of TXG is -12.12
What is the all time high EV/EBITDA for 10x Genomics?
10x Genomics all-time high EV/EBITDA is -8.54
What is TXG EV/EBITDA year-to-date change?
10x Genomics EV/EBITDA has changed by -1.20 (-10.99%) since the beginning of the year
What is 10x Genomics EV/EBITDA year-on-year change?
Over the past year, TXG EV/EBITDA has changed by +16.04 (+56.96%)